Sky News star ‘fell through the gaps' with stage four cancer diagnosis
Former Sky News presenter Dermot Murnaghan has revealed how he 'fell through the gaps' in his healthcare after being diagnosed with stage four prostate cancer, calling his diagnosis a serious 'wake-up call.'
The 67-year-old announced his condition in June and has since been advocating for greater awareness about the importance of testing. Speaking at an event for Prostate Cancer UK, Murnaghan shared the story behind his diagnosis and urged men to be proactive about their health.
He admitted: 'For years I thought 'that will do me' - I'm getting tested basically once a year or every couple of years.' However, he soon realised that the tests he was undergoing privately didn't include screening for PSA (prostate-specific antigen), which is crucial for early detection of prostate cancer.
'It never occurred to me that they weren't testing for PSA, and I never went to my GP because I was getting other tests privately through the production company,' he explained. 'So that's how I fell through the gaps and that's how I had a massive wake-up call and want to share the message.'
Prostate cancer can progress silently without any symptoms. Stage four, which is the most advanced stage, means the cancer has spread beyond the prostate, potentially affecting other organs such as the bladder, bones, lungs, or liver.
Despite its prevalence, affecting about one in eight men in their lifetime, there is currently no routine national screening programme for prostate cancer. The PSA blood test is available but not routinely recommended by the NHS due to concerns about its accuracy. Men over 50 can request the test from their GP.
Murnaghan has now emphasised the importance of insisting on testing, regardless of symptoms or age. 'You can get to the stage I have with no symptoms. Get the test, insist on the test,' he said.
'You can insist on the test if you are in a high-risk group and under 50. If you are not, I'd still get the test at 50. Go to your GP and they say you don't need it but say 'but I want it'. It is your right to have it. Just keep doing that every year or couple of years.'
He also encouraged men to regularly monitor their PSA levels. 'Once you've got that marker where your PSA is, keep monitoring it,' Murnaghan said. 'The earlier you find prostate cancer the easier it is to treat. Check your risk in just 30 seconds with Prostate Cancer UK's online risk checker to see if you are at risk and what you can choose to do about it.'
On treatment, Murnaghan expressed his optimism about new developments as he said: 'In terms of the treatments for the stage I'm at, they are a myriad. What's astonishing is just how fast things are developing."
The former Sky News reporter revealed that the treatment he's receiving was only approved within the last few years. 'There is a lot of hope out there, there's a lot going on, there's a lot of advice and a lot of things happening. As a sufferer and a non-medical person, my advice is ask questions. There are always different ways of doing things… keep asking those questions about where you are and what's available.'
Murnaghan also announced he will take part in Tour de 4, a charity cycling event led by Sir Chris Hoy to raise funds and awareness for cancer charities across the UK.
The Olympian revealed his own terminal prostate cancer diagnosis in October 2024. 'I'm really proud to be supporting Prostate Cancer UK and taking part in Sir Chris Hoy's fundraising event, the Tour de 4,' Murnaghan said.
'This groundbreaking cycling challenge is raising vital funds and changing the conversation. I'll be riding in Glasgow this September alongside some incredible participants, all to raise awareness and help save men's lives. Prostate Cancer UK means a lot to me and I'd love for you to get involved and show your support. Together we can make a real difference."
The Macmillan Support Line offers confidential support to people living with cancer and their loved ones. If you need to talk, call them on 0808 808 0000.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Western Telegraph
2 hours ago
- Western Telegraph
GMB's Dr Hilary Jones travels 360 miles to bypass NHS lists
The well-known television GP from Kent made a 180-mile trip from his home in order to undertake a second hip replacement at a hospital in Birmingham. Now, he is speaking out about his own surgery to show others awaiting treatment that they can also bypass long waiting lists. To do this, he took advantage of NHS Patient Choice after discovering a hospital that had almost no waiting list. Patient choice in the NHS provides patients with a legal right to choose where they receive their NHS healthcare services. GMB star Dr Hilary Jones travels 360 miles to bypass NHS waiting list Speaking after his procedure at Practice Plus Group's new hospital in Birmingham, Doctor Hilary Jones said: 'It was 180 miles from my home to Birmingham - but as it's a new hospital and it's a private hospital that treats NHS patients, they could get me in very quickly just with a referral from my GP. 'I'd do it again in a heartbeat for faster, quality care and highly recommend it. "Patient Choice gives people real power - they just need to know it's there." The GMB and Lorraine star added: "The NHS App is going to be developed further to make this easier, and you can speak to your GP about your choices. 'You can choose to be referred to a private hospital at the outset, or you can switch hospitals like I did if you're facing delays locally. "It's free for the patient and costs the NHS no more than if that same patient had their op at an NHS hospital. "For people like me, who are lucky enough to be mobile despite needing an operation, it makes complete sense to find a hospital that can do your operation sooner so you can get on the road to recovery sooner. 'People don't want to be on a waiting list. They want to get on with their lives. 'Every single person who looked after me was amazing and couldn't have done any more. I am delighted with the result so far.' This comes after a poll of some 1000 adults showed that people awaiting NHS treatment would be willing to travel if it meant they could get what they need sooner. On average, respondents were happy to travel 60 miles if it meant they'd be seen within three to four weeks, or 49 miles for a six-to-eight-week timeframe. Around one in 10 said they would even travel over 200 miles if they could get the NHS surgery they need within a month. Data also found that 55% of Brits had no idea that under NHS Patient Choice, they can choose to travel to a hospital outside of their area. The research, which was commissioned by Practice Plus Group hospitals, which treat NHS patients as well as those who choose their Wellsoon private healthcare option, revealed that 35% would consider travelling more than 90 minutes if it meant saving £200 or more on the cost of paying for a hip or knee replacement. Jim Easton, chief executive, said: 'It's fantastic for patients that in the NHS 10-year plan, the government has renewed its commitment to using capacity in the private sector and to creating a new patient choice charter to ensure the NHS is receptive and reactive to patient preferences. 'To achieve the ambitious waiting time targets, we also need more people to know that they can travel outside of their immediate area if they find a hospital that can see them sooner. Recommended Reading: 'It is important people realise they have the power to be proactive and get their treatment sooner, get back to work and back on track as soon as possible. 'Dr Hilary found this at our Birmingham hospital, which currently can see people in a few short weeks. 'We're proud to have been able to help him and wish him a speedy and healthy recovery.'
Sky News
3 hours ago
- Sky News
Family of woman who died after misdiagnosis by 'substitute doctor' criticise govt review
Why you can trust Sky News The parents of a woman who died after her blood clot was misdiagnosed by someone who she thought was a doctor have called a government-ordered review "a missed opportunity". Marion and Brendan Chesterton have welcomed many of the recommendations in Professor Gillian Leng's review of the role that physician associates (PAs) perform in the NHS, but say "they don't go far enough". Emily died in November 2022 after suffering a pulmonary embolism. She went to see her GP twice in the weeks before her death - and on both occasions was seen by a physician associate who missed the blood clot and instead prescribed propranolol for anxiety. She had told her worried parents that she had been seen by a doctor, but she had not. Her father Brendan told Sky News: "If she come out and said I've seen someone called the physician's associate I'm sure we would have insisted that, you know, let's go back and insist that you see a doctor. She never knew." Now a government-ordered review led by Prof Leng, president of the Royal Society of Medicine, has recommended NHS physician associates should be banned from diagnosing patients who have not already had contact with a doctor for their illness. The report suggests a major change to the role of PAs after it acknowledged they have been used as substitutes for doctors, despite having significantly less training. More than 3,500 PAs and 100 anaesthesia associates (AAs) are working in the NHS and there have been previous calls for an expansion in their number. But a general lack of support for the roles from the medical profession - plus high-profile deaths of patients who were misdiagnosed by PAs - led Health Secretary Wes Streeting to order a review. Presenting her findings, Prof Leng said: "Crucially I'm recommending that PAs should not see undifferentiated or untriaged patients. "If (patients) are triaged, they (PAs) should be able to see adult patients with minor ailments in line with relevant guidance from the Royal College of GPs." She said more detail was needed on which patients can be seen by PAs and national clinical protocols should be developed in this area. She added: "Let's be clear, (the role of PAs) is working well in some places, but there indeed has been some substitution and any substitution is clearly risky and confusing for patients." Prof Leng also recommended PAs should be renamed "physician assistants" to position them "as a supportive, complementary member of the medical team" - and have standardised uniforms to distinguish them from doctors - while AAs should be renamed "physician assistants in anaesthesia". Newly qualified PAs should also work in hospitals for two years before they are allowed to work in GP surgeries or mental health trusts. The report said that while research suggests patients are satisfied after seeing a PA, some did not know they were not seeing a doctor. Prof Leng concluded there were "no convincing reasons to abolish the roles of AA or PA", but there is also no case "for continuing with the roles unchanged". She recommended that both PAs and AAs should have the opportunity for ongoing training and development, with potential to prescribe medicines in the future, and they should also have the opportunity to become an "advanced" PA or AA. Six patient deaths linked to contact with PAs have been recorded by coroners in England. Emily's mother Marion said some of the review's findings were significant and her daughter would still be alive if the recommendations had been in place when she fell ill. She said: "I think so, yes, which is so important, which is why we're so pleased that this review has been made." But Mrs Chesterton added that more could have done, including stopping all PAs from prescribing drugs. "We feel it's a missed opportunity. It could have gone all the way there and cleared things up totally. Our daughter died. She was prescribed a drug that she should not have been prescribed. And it had absolutely catastrophic circumstances. She died for goodness sake." The Chestertons' concerns are shared by the British Medical Association (BMA). Dr Emma Runswick, BMA's deputy chair, said: "It is definitely a problem that the roles of doctors and now physician assistants has been blurred and it's positive that their name is going to change, that there will be a uniform. "But whilst they continue to be deployed in a way that mimics doctors at the behest of any local employer decision, we have to have ongoing concerns about their safety." But UMAPs, the trade union which represents both PAs and AAs, has warned the changes will undermine their qualifications and their role, lengthen waiting lists and worsen the impact of any strike action. "By trying to placate them, at a time when they're striking - and they want their strikes to bite the hardest by taking us out of the workforce - we're now putting patients at risk," said Steve Nash, general secretary of UMAPs. "I think the biggest patient safety risk, out there right now, is the BMA," he added.
The Guardian
5 hours ago
- The Guardian
NHS physician associates should not diagnose untriaged patients, review finds
NHS physician associates should be banned from diagnosing patients who have not already been seen by a doctor, a government review has concluded. The review calls for the government to overhaul the role of physician associates (PAs), who it says have been substituted in for doctors to fill staffing gaps despite having significantly less training. The health secretary, Wes Streeting, ordered the review of the more than 3,500 PAs and 100 anaesthesia associates (AAs) working in the NHS after six high-profile deaths of patients who were misdiagnosed by PAs. Prof Gillian Leng, the president of the Royal Society of Medicine, spoke to more than 1,000 people for the review and concluded there were 'no convincing reasons to abolish the roles of AA or PA' but there was also no case 'for continuing with the roles unchanged'. She wrote in the report: 'Despite the significantly shorter training, PAs and to a lesser extent AAs have sometimes been used to fill roles designed for doctors. The rationale for doing this is unclear, and was probably one of pragmatism and practicality, relying on medical staff to provide the additional expertise when required. 'This lack of planning may have been responsible for driving the resentment felt by some resident [doctors] and potentially exposed patients to unnecessary risk.' One of her main recommendations is that PAs should not see 'undifferentiated or untriaged patients', meaning those who have not yet been diagnosed by a doctor. Leng recommended further work to establish which patients they should be able to see and to set clinical protocols that would enable PAs to diagnose patients with mild ailments. 'Let's be clear, [the role of PAs] is working well in some places, but there indeed has been some substitution and any substitution is clearly risky and confusing for patients,' she said. Leng recommended PAs should be renamed 'physician assistants' and AAs 'physician assistants in anaesthesia' to ensure that patients and their families are clear on whether they have been seen by a doctor. She observed that this confusion was the core concern voiced by the bereaved families she had spoken to, who believed it was a contributing factor in their loved ones' death. She noted in her report that despite the role's rapid expansion since it was introduced in the early 2000s, there was limited data and evidence on whether PAs were safe or unsafe. Most concerns related to PAs being the first clinician to see patients unsupervised. 'Making the wrong initial diagnosis and putting patients on an inappropriate pathway can be catastrophic,' she said. The report found that 'relatively few doctors felt it was appropriate for PAs to diagnose illness' and it identified disparities between the tasks PAs considered right for them to carry out and what doctors thought. Leng recommended that newly qualified PAs work in hospitals for two years before they are allowed to work in GP surgeries or mental health trusts, enabling them to start their careers where there are more training opportunities and supervision. She also recommended more leadership training for doctors, who shared concerns about the lack of preparation for supervision duties, and better career development for PAs and AAs. She suggested a named doctor supervise each PA, while uniforms, lanyards, badges and staff information should be standardised to 'distinguish physician assistants from doctors'. Dr Tom Dolphin, the chair of the British Medical Association, said the report 'laid bare the catastrophic failures in NHS leadership that have put patients at serious risk of harm', but he argued the recommendations did not go far enough on national patient safety standards. 'Prof Leng has succeeded in exposing how NHS England introduced these roles and encouraged their expansion without any robust evidence of their safety,' he said. 'The report reveals inadequate national leadership, no accountability and no attempt to listen to the concerns raised by doctors, patients and coroners. 'The blurring of lines between doctors and non-doctors, aided and abetted by the GMC [General Medical Council], has been an unfolding disaster for all to see, and many doctors today will be relieved to see that they were right to raise the alarm,' Dolphin said. Dr Naru Narayanan, the president of the hospital doctors' union, the HSCA, said: 'Safety concerns will continue until a properly defined national scope is established. The review acknowledges this by calling for standardised job descriptions and clinical protocols. This work needs to be fast-tracked. 'Given how poorly these roles have been defined, and the fact physician assistants earn more after a couple of years of clinical training than resident doctors do after nearly a decade in medicine, it's not surprising there's been tension. We've got a shortage of medical training places and a limited supply of trainers. Additional support and time for senior doctors, as recommended by Prof Leng, are essential.'
